Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02570698 · ClinicalTrials.gov registry record
BM Collection From NICU Infants for Composition
A clinical trial, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 25
- Enrollment target
NCT02570698: Completed study, sponsored by Kimberly-Clark Corporation.
NCT02570698 is a clinical trial that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02570698 has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect feces from premature infants over a five weeks period to characterize its composition. Metabolomics, Proteomics, Genomics and Microbiome analyses and cell-based assays will be performed to identify individual components present in feces, which may contribute to the onset of irritation in the diapered area of premature infants.
Primary Outcome
This is an observational study where fecal samples will be collected twice each week for 5 weeks from enrolled patients. Primary analysis will consist of identification and quantification proteins present in samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-01-23 |
What the finished NCT02570698 record still lists
NCT02570698 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02570698 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02570698 about?
NCT02570698 is a clinical study titled "BM Collection From NICU Infants for Composition". The primary objective of this study is to collect feces from premature infants over a five weeks period to characterize its composition. Metabolomics, Proteomics, Genomics and Microbiome analyses and cell-based assays will be performed to identify individual components present in feces, which may co...
What is the current status of trial NCT02570698?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-10. Estimated completion is 2017-01-23.
Who is sponsoring clinical trial NCT02570698?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia